While p14 ARF suppression of tumorigenesis in a p53-dependent manner is well studied, the mechanism by which p14 ARF inhibits tumorigenesis independently of p53 remains elusive. A variety of factors have been reported to play a role in this latter process. We report here that p14 ARF displays different effects on the anchorage-dependent and -independent growth of p53-null/Mdm2 wild type cells. p14 ARF blocks both the anchorage-dependent and-independent (soft agar) proliferation of 293T and p53 −/− HCT116, but not p53-null H1299 lung carcinoma cells. While p14 ARF had no effect on the anchorage-dependent proliferation of p53 −/− MEFs and Ras12V-transformed p53 −/− MEFs, it inhibited the growth of Ras12V-transformed p53 −/− MEFs in soft agar. Furthermore, ectopic expression of p14 ARF did not lead to degradation of the E2F1 protein and did not result in the reduction of E2F1 activity detected by two E2F1 responsible promoters, Apaf1 and p14 ARF promoter, in 293T, p53 −/− HCT116, and H1299 cells. This is consistent with our observations that p14 ARF did not result in G1 arrest, but induced apoptosis via Bax up-regulation. Taken together, our data demonstrate that the response of p53-null cells to ARF is cell type dependent and involves factors other than Mdm2 and E2F1.
Introduction
The INK4A/ARF locus on human chromosome 9p21 encodes two tumor suppressors, p16 INK4A and p14 ARF , by alternative splicing and the use of different reading frames [1, 2] . They function in the retinoblastoma (Rb) and p53 pathways respectively [2] [3] [4] [5] .
The p14 ARF (p19 ARF for murine, referred to as ARF herein for generic statements) [1, 6] protein stabilizes p53 in response to oncogenic signals. In primary fibroblasts, expression of oncogenic Ras activates p53 in a p19 ARF -dependent manner [7, 8] . Expression of other oncogenes in normal cells, including c-myc, E1A, E2F1, v-Able, and β-catenin, leads to p53 activation through ARF [9] [10] [11] [12] [13] . Furthermore, transgenic mice heterozygous for p19 ARF engineered to express c-myc in B-cells exhibit accelerated B-cell lymphoma with loss of either p53 or ARF function or amplification of Mdm2 [14] , lending in vivo support to the notion that ARF plays an essential role in hyperproliferation-mediated p53 activation. Mechanistically, ARF stabilizes p53 by interaction with Mdm2, the major player in p53 destabilization in vivo. Homozygous deletion of mdm2 results in embryonic lethality in mice [15, 16] , which is rescued by simultaneous deletion of p53 [15, 16] . Mdm2 interacts with the N-terminal region of p53, which contains the acidic transcriptional activation domain [17] . This interaction results in Mdm2 directly inhibiting the transcriptional activity of p53 [17] , suppressing the p300/CBP-mediated p53 acetylation that stabilizes p53 [18] , ligating ubiqitins on p53 [19] , and mediating export of p53 from the nucleus into cytoplasmic proteasomes for degradation [20, 21] . p14 ARF interacts directly with Mdm2, thereby inhibiting the ubiquitin ligase activity of Mdm2 [22] , abolishing the inhibitory activity of Mdm2 on p53 acetylation [18] , and preventing Mdm2-mediated p53 export [23, 24] . Biochimica Therefore, the net result of p14 ARF action is neutralization of the multi-faceted effects of Mdm2 on p53. While it is still unclear how p14 ARF might sense oncogenic signals, c-Myc and E2F1 have been shown to up-regulate the death-associated protein (DAP) kinase that activates p53 via p19 ARF [25, 26] . While compelling evidence supports a p53-dependent role of p14 ARF in tumor suppression, it has become clear recently that ARF also inhibits cell proliferation in the absence of p53 [27] [28] [29] [30] [31] . Both p53 and p14 ARF are targeted for mutation in oral squamous cell carcinoma [32] . Mice deficient for p19 ARF develop more fibrosarcomas than lymphomas, the reverse of the tumor spectrum displayed by p53-null mice [33] . Furthermore, ectopic expression of ARF inhibits the proliferation of p53-null cells [27, 28] . Although ARF inhibits tumorigenesis by stabilization of p53 via inactivation of Mdm2, the mechanisms by which ARF suppresses tumorigenesis independently of p53 is less clear. While ectopic p19 ARF reduces the colonyformation of p53-null MEFs but not those of p53 −/− /Mdm2 −/− [27] , enforced expression of p19 ARF has been shown to inhibit the proliferation of p53 −/− Mdm2 −/− MEFs but not p53 −/− MEFs [28] . Thus, the role of Mdm2 in mediating p53independent function of ARF remains elusive. p14 ARF interacts with and inhibits hypoxia-inducible factor-1α (HIF-1α)-mediated transcription, a process that is independent of both p53 and Mdm2 [31] . Both human and murine ARFs bind E2F1, resulting in the degradation of E2F1 and the inhibition of p14 ARF cells were constructed and single cell clones were selected (Materials and methods). The p14 ARF protein was induced by doxycyclin (Dox) at 2 μg/ml for the indicated times and detected by western blot using an anti-FLAG antibody (M2). The expression of E2F1, p21 CIP1 (p21), p53, Mdm2, and actin was also examined using specific antibodies. (B) 293 Teton pTET-1 and 293 Teton p14 ARF cells were cultured in the presence of Dox for 2 days, followed by immunofluorescent staining for p14 ARF using M2 (green). Nuclei were counter-stained with DAPI (blue). (C) 10 5 pTET-1 (vector control), ARF2, and ARF3 of single cell clones of 293 Teton p14 ARF cells were seeded in duplicate in 6-well plates and cultured with or without Dox for a period of 8 days with cell number being counted every 2 days. Experiments were repeated three times and the summary of these experiments is shown. Similar growth curves were also obtained for several other Tet-inducible p14 ARF single cell cones (data not shown). (D) 100 pTET-1 and ARF2 cells were seeded in a 6-well plate, cultured with or without Dox (2 μg/ml) for 2 weeks, and stained with 0.1% crystal violet. Identical results were also obtained using other single cell clones (data not shown). Experiments were repeated at least three times. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.) E2F1 transcriptional activity, which may contribute to p53independent function of ARF [30, 34, 35] .
We report here a heterogeneous response of p53-null cells to p14 ARF . p14 ARF inhibits both anchorage-dependent and -independent growth of 293T and p53 −/− HCT116 cells, reduces the proliferation of RasV12-transformed p53 −/− MEFs on soft agar but not on monolayer, and has no effect on either the anchorage-dependent or -independent growth of H1299 p53null cells. As all these cells contain Mdm2 and we detected no p14 ARF -mediated alterations in E2F1 protein levels and its activity in these cells, our research reveals the existence of additional factors besides Mdm2 and E2F1 in regulating p53independent function of p14 ARF . were cultured in RPMI1640, 10% FCS. Human p14 ARF was cloned from C33A cervical carcinoma cells by PCR amplification and expressed as a C-terminal FLAG tagged protein using pcDNA3, pBabe, pTET-1, and pRevTRE vectors. pTET-1 and pRevTRE are tetracycline-responsive vectors. pBabe and pRevTRE are retroviral vectors. A retroviral vector expressing Teton (pRevTeton) was purchased from Clontech. Plasmids expressing retroviral gag-pol (GP) and VSV-G proteins were purchased from Stratagene. Apaf1 promoter luciferase and p14 ARF promoter luciferase constructs were kindly provided by Drs. Kristian Helin and Kiyoshi Ohtani, respectively.
Materials and methods

Retroviral infection
Retroviral infection was performed as we have published with modifications [36] [37] [38] [39] . Retroviral plasmid was co-transfected into 293T cells with GP and VSV-G plasmids using a calcium phosphate method for 48 h. Virus-containing medium was harvested and used to infect target cells in the presence of 10 μg/ml of polybrene (Sigma). Infected cells were cultured in medium containing appropriate antibiotics. To determine retrovirus titer, a LacZ retrovirus without a mammalian selection marker was co-packed with a designated retrovirus at a ratio of 1:5 (LacZ : cDNA of interest). Virus was used to infect NIH3T3 cells for 36 h before staining for LacZ. Comparable levels of staining among individually packed retroviruses indicate comparable titers.
Generation of tetracycline (Tet) inducible p14 ARF expressing cell lines
The p53 −/− MEFs were infected with pRevTeton retrovirus and selected in G418 to yield p53 −/− MEF Teton cells, which were then infected with pRevTet/ Fig. 2 . Ectopic p14 ARF does not affect the anchorage-independent proliferation of p53 −/− MEFs. (A) Tet-inducible p53 −/− MEF Teton p14 ARF cells (passage 16) were constructed using a retroviral system (Materials and methods) and the pooled population was used. p14 ARF was induced by Dox (2 μg/ml) for 2 days and examined for the expression of ectopic p14 ARF , Mdm2, endogenous p19 ARF , and actin using M2 antibody (for ectopic p14 ARF ) (left panel) and other specific antibodies. Two hundred cells were seeded in 6-well plates in triplicate and cultured in the presence or absence of Dox for 2 weeks. The colonies were stained with 0.1% crystal violet and numbers of colonies were graphed (right panel). The experiment was repeated twice. (B) Tet-inducible p53 −/− MEF Teton p14 ARF cells were infected with either a control retrovirus (pBabe) or a Ras12V retrovirus and selected in puromycin. Erk activation and the expression of Erk, Mdm2, endogenous p19 ARF , and actin in those cells were determined by western blot using specific antibodies (left panel). The growth rate of those cells was examined (right panel). p14 ARF and cultured in hygromycin-containing medium to generate p53 −/− MEF Teton p14 ARF cells. The 293 Teton p14 ARF cells were constructed by transfection of 293 Teton cells with pTET-1/p14 ARF using a calcium phosphate method. Single cell clones were selected in hygromycin-containing medium. Induction of p14 ARF was carried out by addition of doxycycline, a Tet analogue.
Cell cycle analysis
Cell cycle distribution was determined by staining 293 Teton p14 ARF cells with propidium iodide (PI) solution in the presence of RNase A overnight at 4°C, followed by the analysis of DNA contents using a flow cytometer [38] .
Growth curve, colony formation, and soft agar assays
For growth curves, 10 5 293 Teton p14 ARF or 293 Teton pTET-1 (control) cells in duplicate were seeded in 6-well plates for 24 h before addition of Dox (2 μg/ml). Cell numbers were counted every other day. To assess colony formation, 100 to 200 cells were seeded into 6-well plates and cultured for about 2 weeks with or without Dox until colonies formed, which were stained with 0.1% crystal violet. For soft agar assay, 2 ml of 0.5% agar in DMEM, 10% FCS was plated in 6-well plates, followed by seeding 10 4 cells, which were resuspended in 0.3% agar dissolved in DMEM, 10% FCS, on the top of solidified agar. Cells were then cultured in a tissue culture incubator for 3 weeks supplemented with 100 μl media every 2 or 3 days until colonies formed.
Cell lysis and western blot
Cell lysate was prepared and western blot performed according to our published procedure [38] . Primary antibodies and concentrations used were: anti-FLAG (M2 at 3 μg/ml, Sigma); anti-p53 (FL-353 at 1 μg/ml, Santa Cruz); anti-E2F1 (1 μg/ml, Santa Cruz); anti-Actin (0.5 μg/ml, Santa Cruz); anti-p21 CIP1 (1 μg/ml, Santa Cruz); anti-p19 ARF (5-C3-1, Santa Cruz); anti-MDM2 (SMP14, Santa Cruz).
Immunofluorescent detection of p14 ARF
Cells were fixed with pre-chilled Acetone/Methanol (3:7) and incubated for 2 h with affinity-purified antibodies: a monoclonal anti-FLAG antibody (M2 at 1 μg/ml, Sigma), followed by incubation with FITC-conjugated anti-mouse IgG (1:200, Jackson Immnuno Research). Immunofluorescence was detected using a fluorescent microscope (Carl Zeiss, Axiovert 200).
Luciferase assays
293 Teton p14 ARF cells were seeded in 24-well plate in triplicate, transfected with 0.5 μg β-Gal, 0.5 μg Apaf1 or p14 ARF luciferase constructs using PEI (Sigma), followed by induction of p14 ARF expression with Dox for 48 h before assay for luciferase activity using the Stop and Glo Luciferase Assay Kit (Promega). β-gal assays were performed as usual, and Luciferase Values were then divided by β-gal values to normalize luciferase activity. For p53 −/− HCT116 and H1299 cells, they were seeded in 24-well plate in triplicate, infected with pBabe or pBabe-p14 ARF for 24 h, and then transfected with 0.5 μg β-Gal and 0.5 μg Apaf1-luciferase using LipofectAMINE2000 (Invitrogen) for 30 h, which was followed by assay for β-gal and luciferase activity as described above.
Results
Expression of p14 ARF attenuates the proliferation of 293 Teton cells
Although much is known about the mechanism by which p14 ARF functions in a p53-dependent manner, less is known about its p53-independent function. To investigate this process, a tetracycline (Tet)-inducible p14 ARF (FLAG tagged) cell line was constructed using 293 Teton cells (derivatives of 293T cells). Fig. 3 . p14 ARF inhibits the anchorate-independent growth of 293T and RasV12 transformed p53 −/− MEFs. The ARF2 (similar results were obtained from other single cell clones, data not shown) of Tet-inducible 293 Teton p14 ARF cells and Ras12V transformed Tet-inducible p53 −/− MEF Teton p14 ARF cells were cultured in soft agar containing Dox (2 μg/ml). The MEFs were cultured for 2 days as monolayer with or without Dox before being seeded into a 6-well agar plate at 10 4 cells/well. Cells were cultured on soft agar for 3 weeks before being photographed.
Dox, a tetracycline analogue, induced p14 ARF expression by 12 h, which peaked at 2 days of Dox exposure (Fig. 1A) . The absence of p53 function, which is due to the expression of adenovirus transforming proteins [40] , in 293 Teton cells was confirmed. Etoposide (a DNA damage reagent) is unable to further stabilize p53 and up-regulate p21 CIP1 in 293 Teton cells (data not shown) and ectopic p14 ARF was unable to up-regulate either p53 or its transcriptional targets p21 CIP1 and Mdm2 (Fig.  1A) . Consistent with reports [23, 24] , ectopic p14 ARF was expressed largely in the nucleoli (Fig. 1B) . To examine the effects of ectopic p14 ARF on 293 Teton cell proliferation, we examined the growth rate of 293 Teton pTET-1 (control cells) and 293 Teton p14 ARF cells. Both cells were seeded at 10 5 /well in 6well plates and cultured with or without Dox (2 μg/ml) for a period of 8 days with cell numbers recorded every 2 days. While Dox had no effect on the proliferation of 293 Teton pTET-1 cells (comparing the proliferation of these cells with and without Dox addition), induction of p14 ARF substantially inhibited 293 Teton p14 ARF cells proliferation (Fig. 1C) . The same results were also obtained in at least 6 additional single cell clones (data not shown), which validates the observed inhibition of p14 ARF on 293T cell proliferation being not resulted from possible artifacts of single cell cloning.
To consolidate this observation, a colony formation assay was also performed. The plating efficiency of these cells was first determined to permit the generation of 30 colonies in a 6well tissue culture plate. One hundred cells/well were subsequently seeded in a 6-well plate and cultured with or without Dox (2 μg/ml) for 2 weeks. The cell colonies were then stained with 0.1% crystal violet. In comparison with the pTET-1 cells, Dox-induced ARF profoundly inhibited colony formation in the ARF cells ( Fig. 1D ). Taken together, the above results reveal that p14 ARF inhibits 293 Teton cell proliferation.
p14 ARF inhibits the anchorage-independent but not -dependent proliferation of p53 −/− MEFs
Despite lack of any detectable function, the p53 protein is highly expressed in 293 Teton cells (Fig. 1A) . To rule out any contributions of the p53 protein toward ARF function in these cells, we examined ARF function in p53 −/− MEF cells. We constructed Tet-inducible p14 ARF expressing p53 −/− MEFs using late passage (p16) cells (for methodology, see Materials and methods). While Dox induced the expression of p14 ARF protein in these cells ( Fig. 2A, left penal) , ARF did not reduce either the growth rate (data not shown) or the efficiency of colony formation ( Fig. 2A, right panel) . Consistent with a report [10] , p53 −/− MEFs express high levels of endogenous p19 ARF , which was not affected by p14 ARF induction ( Fig. 2A, left  panel) . In keeping with the observation that p14 ARF did not result in changes in Mdm2 expression in 293T cells (Fig. 1A) , induction of p14 ARF did not affect Mdm2 expression in p53 −/− MEFs ( Fig. 2A, left panel) . However, as p14 ARF inhibits the proliferation of 293T (Fig. 1C, D) but not p53 −/− MEF cells ( Fig. 2A, right panel) , this implies that Mdm2 may not be the major factor in modulating p53-independent function of p14 ARF . As the expression level of p14 ARF induced by Dox in these cells was substantially lower than that in 293 Teton p14 ARF cells (data not shown), lack of inhibition on the proliferation of p53 −/− MEFs by p14 ARF might be attributable in part to a low level of the ARF protein.
293 Teton cells are cancerous, while the late passage (immortal) p53 −/− MEFs are not. To investigate whether transformation status of p53 non-functional cells is associated with p14 ARF -mediated growth inhibition, we infected Tetinducible p53 −/− MEF p14 ARF cells with either pBabe (an empty vector control) or pBabe/Ras12V retrovirus. Compared to pBabe infection, ectopic Ras12V induced typical spindle like morphology (data not shown), indicative of cell transformation, and Erk activation (Fig. 2B, left panel) , as well as promoted MEF proliferation (Fig. 2B, right panel) . Consistent with Mdm2 up-regulation by the Ras/MEK/Erk pathway [41] , RasV12 increased Mdm2 expression ( Fig. 2B, left panel) . Although Fig. 4 . Ectopic p14 ARF suppresses the anchorage-dependent and -independent proliferation of p53 −/− HCT116 colon cancer cells but not p53-null lung carcinoma H1299 cells. HCT116, p53 −/− HCT116, and H1299 cells were infected with either a vector retrovirus (pBabe) or an ARF retrovirus (pBabe/ p14 ARF ) and selected in puromycin. (A) Expression of p14 ARF , E2F1, Mdm2, and actin in these cells after infection for 2 days was determined with western blot using specific antibodies. (B) Colonies formed on monolayer for individual cell population as indicated was determined. (C) The individual cell populations after selection in puromycin for 2 days were seeded into puromycin-containing soft agar and cultured for 3 weeks. Colonies numbers are graphed. Experiments were repeated twice.
RasV12 has been reported to induce p19 ARF in primary cells [8] , it did not increase p19 ARF in p53 −/− MEFs (Fig. 2B, left  panel) , which may be attributable to the immortalization nature of these cells (>passage 16). In comparison with parental cells, induction of p14 ARF by Dox was not altered by either pBabe or Ras12V infection (data not shown). p14 ARF induction had no effect on the proliferation of RasV12 infected cells (Fig. 2B,  right panel) and on the colony formation of these cells (data not shown). Thus, the transformation status of p53 −/− MEFs does not appear to dictate p14 ARF function in these cells.
To further test this notion, the effect of ectopic p14 ARF on the anchorage-independent proliferation (in soft agar) of p53-null cells was examined. Both Tet-inducible 293 Teton p14 ARF and RasV12 transformed p53 −/− MEF teton p14 ARF cells were seeded in soft agar with or without Dox (Fig. 3 ). Induction of p14 ARF clearly blocked the growth of both cells on soft agar (Fig. 3) . This is consistent with a recent report showing that p14 ARF prevented the tumor formation of H358 cells, p53-null bronchioloalveolar lung adenocarcinoma, in nude mice [42] . Collectively, while the expression of p14 ARF is not inhibitory to the anchorage-dependent proliferation of Ras12V transformed p53 −/− MEFs, it prevents the growth of these cells in soft agar.
The p53-independent function of p14 ARF is cell type specific
The fact that ectopic p14 ARF inhibits the anchoragedependent proliferation of 293T but not p53-null MEFs (Figs. 1, 2) reveals that p14 ARF affects the proliferation of p53-null cells in a cell-specific manner. To further address this issue, we infected p53-null lung carcinoma H1299 [6, 43] and colon cancer p53 −/− HCT116 cells with pBabe and pBabe/p14 ARF retrovirus. The p53 −/− HCT116 cells, kindly provided by Dr. Vogelstein, were derived from HCT116 cells by homologous recombination [44] . Expression of p14 ARF in the infected cells was confirmed (Fig. 4A ). As expected, ectopic p14 ARF upregulated Mdm2 (Fig. 4A) , which was attributed through p14 ARF -mediated p53 stabilization. Compared to HCT116 cells, p53 −/− HCT116 was less sensitive to p14 ARF -mediated inhibition of anchorage-dependent and -independent growth (Fig. 4B, C) , an observation consistent with ARF's p53dependent function. Despite being expressed at a much higher level in H1299 than in p53 −/− HCT116 cells (Fig. 4A) , p14 ARF reduces the anchorage-dependent and -independent growth of p53 −/− HCT116 but not H1299 cells (Fig. 4B, C) . The reduction in colony numbers of p14 ARF -infected HCT116 and p53 −/− HCT116 cells on monolayer (Fig. 4B ) and on soft agar (Fig. 4C) was not due to lower titer of pBabe/p14 ARF virus than that of pBabe because compatible numbers of puromycin resistant colonies were obtained from pBabe and p14 ARF infected H1299 cells (Fig. 4B, C) . This observation also reveals that p53 nonfunctional H1299 cells are resistant to p14 ARF -mediated inhibition. The substantially lower level of p14 ARF protein, expressed in HCT116 cells than that expressed in p53 −/− HCT116 cells, was due to a p53-mediated negative-feedback regulation on ARF [6, 45] . Since Mdm2 levels in p53 −/− HCT116 and H1299 cells did not change with and without ectopic p14 ARF , Mdm2 does not play a major role in the regulation of p53-independent function of ARF in thee two cell lines. The fact that p14 ARF was expressed at a much higher level in the ARF non-functional H1299 cells than that in ARF functional p53 −/− HCT116 cells (Fig. 4A ) may indicate a p53- Fig. 5 . The effects of p14 ARF on E2F1 activity in p53-null function cells. 293 Teton p14 ARF cells were transfected with β-Gal and Apaf1-luciferase (right two bars) or p14 ARF -luciferase (left two bars) and then induced for p14 ARF expression by Dox (Materials and methods) for 48 h. p53 −/− HCT116 and H1299 cells were infected with pBabe or p14ARF retrovirus and then transfected with β-Gal and Apaf1-luciferase (Materials and methods). After determining β-Gal and Apaf1-luciferase, luciferase activity was normalized against β-Gal activity and the luciferase activity in p14 ARF expressing cells was presented as % of the luciferase activity in control cells. Experiments were repeated at least twice and a representative of these is shown. The difference in luciferase activity between cells with and without ARF expression is not statistically significant.
independent negative feedback regulation of ARF. Taken together, these observations demonstrate that the p53-independent function of p14 ARF is a rather complex issue.
p14ARF inhibits the proliferation of p53-null cells without inducing E2F1 degradation
p19 ARF has been reported to inhibit 293T cell proliferation via the induction of E2F1 degradation [30] . To determine whether this applies to p14 ARF , we examined E2F1 protein in multiple p53 non-functional cell lines with or without ectopic p14 ARF . It was found that p14 ARF did not lead to downregulation of the E2F1 protein in 293 Teton , p53 −/− HCT116, and H1299 cells ( Figs. 1A and 4A) , an observation consistent with reports [34, 35] . However, p14 ARF has been reported to inhibit the transcriptional activity of E2F1 in p53-null Saos2 cells without causing its down-regulation [34, 35] . To examine whether p14 ARF inhibits E2F1 function in our system, we transfected 293 Teton p14 ARF cells with a luciferase reporter driven by either Apaf1 or p14 ARF promoter, two E2F1 responsible promoters [46, 47] . Induction of p14 ARF by Dox did not lead to inhibition of either promoter (Fig. 5 ). Similar observation was also obtained in p53 −/− HCT116, and H1299 cells (Fig. 5 ). Thus, our results are not consistent with p14 ARF -mediated inhibition of E2F1 activity observed in Saos2 (p53-null ) cells [34, 35] . This discrepancy might be caused by the use of different p53 non-functional cell lines. Taken together, the above data reveal the existence of factors besides E2F1 in the regulation of p53-independent function of p14 ARF .
p14 ARF induces apoptosis in 293T cells via Bax up-regulation
To characterize p14 ARF -mediated inhibition of 293 Teton cell proliferation, we have examined whether p14 ARF induces cell cycle arrest. Upon induction of p14 ARF from day 1 to day 4, Fig. 6 . Ectopic p14 ARF does not alter cell cycle distribution but induces apoptosis. (A) The 293 Teton p14 ARF cells were treated with Dox (2 μg/ml) as indicated and cell cycle distribution was determined (38) . (B) The ARF2 cells were induced for ARF expression as indicated. Apoptotic cells were examined by TUNEL (green). Nuclei were counter-stained with DAPI (blue). The same results were also obtained using three other single cell clones (data not shown). Experiments were repeated twice. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.) which covers the maximal p14 ARF induction (Fig. 1A) , we did not observe any differences in cell cycle distribution among mock and Dox-treated cells (Fig. 6A ). This not only supports the concept that p14 ARF inhibits 293T cell proliferation via an E2F1independent function but also suggests that p14 ARF reduces 293T cell proliferation through the induction of apoptosis. This is consistent with our observation that p14 ARF -mediated inhibition of 293T cell proliferation (Fig. 1C ) was largely compromised if initial cells were seeded at a higher density (10 6 / well) (data not shown). This also agrees with the fact that BrDU labeling did not reveal significant differences with and without p14 ARF induction at this cell density (data not shown). Collectively, the above observations suggest that p14 ARF may affect cell survival rather than cell proliferation.
To examine whether p14 ARF induces 293T cell apoptosis, we were able to show low levels of apoptosis following p14 ARFinduction (Fig. 6B ). This agrees with the density-dependent growth inhibition of 293T cells imposed by ectopic p14 ARF . To determine how p14 ARF induces apoptosis in 293T cells, we examined whether p14 ARF facilitates the expression of Bcl-2 and two pro-apoptotic Bcl-2 family members (Bak and Bax) with multiple BH (Bcl-2 homology) domains. While p14 ARF does not affect Bcl-2 and Bak expression, it increases Bax expression between 1.5 to 2.5 fold (Fig. 7) . Taken together, the above data support the notion that p14 ARF induces apoptosis in 293T cells via at least in part Bax up-regulation.
Discussion
Mounting evidence supports the concept of ARF possessing functions that are independent of p53. Unlike the p53dependent functions, the mechanism by which ARF suppresses tumorigenesis independently of p53 is poorly understood. A variety of proteins have been reported to play a role in this process, including Mdm2 [27, 28] , HIF-1α [31] , E2F1 [30, 34, 35] , Cdc25C [42] , dihydrofolate reductase (DHFR) [48] , and nucleophosmin/B23 [49] .
We have investigated ARF function in several p53-null function cell lines, including 293 Teton , p53 −/− MEF, p53 −/− HCT116, and H1299. While ectopic p14 ARF is functional in the first three lines, it is not in H1299 cells. Although p19 ARF induces E2F1 protein degradation in 293T and MDA/MB231 p53 mutated cells [30] , we did not observe a reduction in E2F1 protein by p14 ARF in any of the p53-null cell lines used here. Consistent with the observation of p19 ARF inducing E2F1 degradation in U2OS (p53 wild type) cells [30] , we found that p14 ARF induced approximately 90% and more than 50% E2F1 down-regulation in U2OS (data not shown) and HCT116 cells (Fig. 4A) , respectively. Knocking out p53 from HCT116 cells abolished p14 ARF -mediated down-regulation of E2F1 (Fig.  4A) , demonstrating an important role of p53 in this process. The difference between p19 ARF and p14 ARF in the induction of E2F1 protein degradation in p53-null cells might be attributed to the differences between these two ARFs [50, 51] . While it was reported that p14 ARF did not induce E2F1 protein degradation, its association with E2F1 inhibited the transcriptional activity of E2F1 [34, 35] . It is thus possible that murine and human ARF inactivates E2F1 in the absence of p53 via different mechanisms. However, ectopic p14 ARF does not arrest 293 Teton cells in G1 phase (Fig. 6A) , consistent with the observation that p14 ARF did not reduce E2F1 activity in these cells (Fig. 5 ). Thus, E2F1 might not be a universal target of p14 ARF in p53 deficient cells. The fact that ectopic p14 ARF was expressed to substantially higher levels in H1299 than in p53 −/− HCT116 cells (Fig. 4A ) suggests a negative-feedback regulation in p53 −/− HCT116 cells, which is defective in H1299 cells. It will be of great interests to determine the nature of this p53-independent ARF feedback regulation.
While Mdm2 plays a major role in p14 ARF -mediated p53 activation, it might not be involved in the p53-independent function of ARF. Mdm2 has been reported to be required for p19 ARF function or to be inhibitory to p19 ARF function in p53 −/− MEFs [27, 28] . While we have found that p14 ARF is not inhibitory to the anchorage-dependent proliferation of p53 −/− Fig. 7 . Ectopic expression of p14 ARF up-regulates Bax in 293 Teton p14 ARF cells. ARF2 cells were induced for 2 days by Dox (2 μg/ml) and examined for the expression of ARF, Bax, Bak, Bcl-2, and actin by western blot using specific antibodies (left panel). The cells were also induced by Dox for a period of 8 days. The induction of p14 ARF expression was confirmed (top, right panel). Bax expression was examined by western blot and plotted (right panel). Experiments were repeated twice.
MEFs, it blocks the anchorage-independent growth of RasV12 transformed p53 −/− MEFs (Fig. 3 ). While the mechanism underlying p14 ARF -mediated inhibition of anchorage-independent growth of RasV12 transformed p53 −/− MEFs is unclear, this observation may indicate a role of p14 ARF in integrin signaling. Furthermore, although p53-null MEF, p53 −/− HCT116 and H1299 cells are Mdm2 positive (Figs. 2, 4) , p14 ARF inhibits the anchorage-independent proliferation of p53 −/− MEFs and p53 −/− HCT116 but not H1299 cells (Figs.  3, 4 ). Thus, Mdm2 may not be a major factor in the regulation of ARF function without p53. This is consistent with recent developments showing that the interaction of ARF with Mdm2 in the nucleoplasm is required for ARF to activate p53. Moreover, enforced localization of ARF to the nucleolus abolishes the binding of ARF to Mdm2, and thereby leading to the inability of ARF to activate p53 [49] . Furthermore, the nucleolar location of ARF does not require p53 and inhibits preribosomal RNA processing and nucleophosmin/B23 function [52] [53] [54] . Thus, our observation supports the existence of additional factors besides Mdm2 in the regulation of ARF's p53-independent function. Taken together, we provide evidence here that ARF inhibits the proliferation of p53 deficient cells in a cell-specific manner and this process involves additional factors other than E2F1 and Mdm2.
